Cycloserine
Active ingredient: Cycloserine
In short: Cycloserine is indicated in the treatment of active pulmonary and extrapulmonary tuberculosis (including renal disease) when the causative organisms are susceptible to this drug and when treatment with the primary medications (streptomycin, isoniazid, rifampin, and ethambutol) has proved inadequate.
What is Cycloserine used for?
Cycloserine is indicated in the treatment
of active pulmonary and extrapulmonary
tuberculosis (including renal disease) when
the causative organisms are susceptible to
this drug and when treatment with the primary
medications (streptomycin, isoniazid, rifampin,
and ethambutol) has proved inadequate. Like
all antituberculosis drugs, cycloserine should be
administered in conjunction with other effective
chemotherapy and not as the sole therapeutic
agent.
Cycloserine may be effective in the treatment
of acute urinary tract infections caused by
susceptible strains of gram-positive and gram-
negative bacteria. Use of cycloserine in these
infections should be considered only when
more conventional therapy has failed and when
the organism has been demonstrated to be
susceptible to the drug
âš Boxed warning (FDA's strongest warning)
Administration of cycloserine should be discontinued or the dosage reduced if the patient develops allergic dermatitis or symptoms of CNS toxicity, such as convulsions, psychosis, somnolence, depression, confusion,
hyperreflexia, headache, tremor, vertigo paresis, or dysarthria.
The toxicity of cycloserine is closely related to excessive blood levels (above 30 mcg/mL), as determined by high dosage or inadequate renal clearance. The ratio of toxic dose to effective dose in tuberculosis is small.
The risk of convulsions is increased in chronic alcoholics.
Patients should be monitored by hematologic, renal excretion, blood level, and liver function studies.
Cycloserine dosage
Cycloserine is effective orally and is currently administered only by this route. The usual dosage is 500 mg to 1 g daily in divided doses monitored by blood levels.1 The initial adult dosage most frequently given is 250 mg twice
daily at 12-hour intervals for the first 2 weeks. A daily dosage of 1 g should not be exceeded.
Warnings & precautions
Do not take this medicine if: Administration is contraindicated in patients with
any of the following:
• Hypersensitivity to cycloserine
• Epilepsy
• Depression, severe anxiety, or psychosis
• Severe renal insufficiency
• Excessive concurrent use of alcoho
General: Before treatment with cycloserine is initiated, cultures should be taken and the organism’s susceptibility to the drug should be established. In tuberculous infections, the organism’s susceptibility to the other antituberculosis agents in the regimen should also be demonstrated.
Anticonvulsant drugs or sedatives may be effective in controlling symptoms of CNS toxicity, such as convulsions, anxiety, and tremor. Patients receiving more than 500 mg of cycloserine daily should be closely observed for such symptoms. The value of pyridoxine in preventing CNS toxicity from cycloserine has not been proved.
Administration of cycloserine and other antituberculosis drugs has been associated in a few instances with vitamin B 12 and/or folic-
acid deficiency, megaloblastic anemia, and sideroblastic anemia. If evidence of anemia develops during treatment, appropriate studies and therapy should be instituted.
Laboratory Tests: Blood levels should be determined at least weekly for patients with reduced renal function, for individuals receiving a daily dosage of more than 500 mg, and for those showing signs and symptoms suggestive of toxicity. The dosage should be adjusted to keep the blood level below 30 mcg/mL.
Drug Interactions: Concurrent administration of ethionamide has been reported to potentiate neurotoxic side effects.
Alcohol and cycloserine are incompatible, especially during a regimen calling for large doses of the latter. Alcohol increases the possibility and risk of epileptic episodes.
Concurrent administration of isoniazid may result in increased incidence of CNS effects, such as dizziness or drowsiness. …
Cycloserine side effects
Most adverse reactions occurring during therapy with cycloserine involve the nervous system or are manifestations of drug hypersensitivity. The following side effects have been observed in patients receiving cycloserine:
Nervous system symptoms (which appear to be related to higher dosages of the drug, i.e., more than 500 mg daily)
• Convulsions • Drowsiness and somnolence • Headache • Tremor • Dysarthria • Vertigo
• Confusion and disorientation with loss of memory • Psychoses, possibly with suicidal tendencies • Character changes • Hyperirritability • Aggression • Paresis • Hyperreflexia • Paresthesia • Major & minor (localized) clonic seizures • Coma
Cardiovascular: Sudden development of congestive heart failure in patients receiving 1 to 1.5 g of cycloserine daily has been reported.
Allergy (apparently not related to dosage)
Skin rash
Miscellaneous: Elevated serum transaminase, especially in patients with preexisting liver disease
To report SUSPECTED ADVERSE REACTIONS, contact Cerovene, Inc. at 1-833-304-9569 or FDA at 1‑800-FDA-1088 or www.fda.gov/medwatch.
About this medicine
D -Cycloserine, (R)-4-amino-3-isoxazolidinone,
is a broad-spectrum antibiotic that is produced
by a strain of Streptomyces orchidaceus and has
also been synthesized. Cycloserine is a white
to off-white powder that is soluble in water and
stable in alkaline solution. It is rapidly destroyed
at a neutral or acid pH.
Cycloserine has a pH between 5.5 and 6.5 in a
solution containing 100 mg/mL. The molecular
weight of cycloserine is 102.09, and it has an
empirical formula of C 3H6N2O 2 . The structural
formula of cycloserine is as follows:
Each capsule contains cycloserine, 250 mg
(2.45 mmol); D & C Yellow No. 10, F D & C Blue
No. 1, F D & C Red No. 3, F D & C Yellow No.
6, gelatin, iron oxide, talc, and titanium dioxide.
How it works: After oral administration, cycloserine is readily absorbed from the gastrointestinal tract, with peak blood levels occurring in 4 to 8 hours. Blood levels of 25 to 30 mcg/mL can generally be maintained with the usual dosage of 250 mg twice a day, although the relationship of plasma levels to dosage is not always consistent. …
Source: FDA-approved label via DailyMed (U.S. National Library of Medicine), label set ID 8e7e2665-7a3d-3f54-9f92-5fe845f02ef9. Read the full official label on DailyMed.
Related medicines
Amoxicillin Azithromycin Doxycycline Amoxicillin and Clavulanate Cephalexin Valacyclovir Sulfamethoxazole and Trimethoprim Nitrofurantoin